152 related articles for article (PubMed ID: 24995550)
1. Outcome of advanced, unresectable conventional central chondrosarcoma.
van Maldegem AM; Gelderblom H; Palmerini E; Dijkstra SD; Gambarotti M; Ruggieri P; Nout RA; van de Sande MA; Ferrari C; Ferrari S; Bovée JV; Picci P
Cancer; 2014 Oct; 120(20):3159-64. PubMed ID: 24995550
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study.
Frezza AM; Cesari M; Baumhoer D; Biau D; Bielack S; Campanacci DA; Casanova J; Esler C; Ferrari S; Funovics PT; Gerrand C; Grimer R; Gronchi A; Haffner N; Hecker-Nolting S; Höller S; Jeys L; Jutte P; Leithner A; San-Julian M; Thorkildsen J; Vincenzi B; Windhager R; Whelan J
Eur J Cancer; 2015 Feb; 51(3):374-81. PubMed ID: 25529371
[TBL] [Abstract][Full Text] [Related]
3. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
4. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
[TBL] [Abstract][Full Text] [Related]
5. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
[TBL] [Abstract][Full Text] [Related]
6. The presentation, treatment and outcome of periosteal chondrosarcoma in the Netherlands.
Goedhart LM; Ploegmakers JJ; Kroon HM; Zwartkruis EC; Jutte PC
Bone Joint J; 2014 Jun; 96-B(6):823-8. PubMed ID: 24891585
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Grimer RJ; Gosheger G; Taminiau A; Biau D; Matejovsky Z; Kollender Y; San-Julian M; Gherlinzoni F; Ferrari C
Eur J Cancer; 2007 Sep; 43(14):2060-5. PubMed ID: 17720491
[TBL] [Abstract][Full Text] [Related]
8. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.
Söderström M; Ekfors TO; Böhling TO; Teppo LH; Vuorio EI; Aro HT
Acta Orthop Scand; 2003 Jun; 74(3):344-50. PubMed ID: 12899557
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated central chondrosarcoma.
Staals EL; Bacchini P; Bertoni F
Cancer; 2006 Jun; 106(12):2682-91. PubMed ID: 16691621
[TBL] [Abstract][Full Text] [Related]
10. Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
van Maldegem A; Conley AP; Rutkowski P; Patel SR; Lugowska I; Desar IME; Bovée JVMG; Gelderblom H
Oncologist; 2019 Jan; 24(1):110-116. PubMed ID: 30082492
[TBL] [Abstract][Full Text] [Related]
11. Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up.
Ogura K; Fujiwara T; Beppu Y; Chuman H; Yoshida A; Kawano H; Kawai A
Arch Orthop Trauma Surg; 2012 Oct; 132(10):1379-86. PubMed ID: 22678528
[TBL] [Abstract][Full Text] [Related]
12. Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas.
Bernstein-Molho R; Kollender Y; Issakov J; Bickels J; Dadia S; Flusser G; Meller I; Sagi-Eisenberg R; Merimsky O
Cancer Chemother Pharmacol; 2012 Dec; 70(6):855-60. PubMed ID: 23053256
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal chondrosarcoma: a report of 17 cases.
Harwood AR; Krajbich JI; Fornasier VL
Clin Orthop Relat Res; 1981; (158):144-8. PubMed ID: 7273513
[TBL] [Abstract][Full Text] [Related]
14. Chondrosarcoma of the scapula: long-term oncologic outcome.
Pant R; Yasko AW; Lewis VO; Raymond K; Lin PP
Cancer; 2005 Jul; 104(1):149-58. PubMed ID: 15895373
[TBL] [Abstract][Full Text] [Related]
15. Epithelioid sarcoma: Still an only surgically curable disease.
de Visscher SA; van Ginkel RJ; Wobbes T; Veth RP; Ten Heuvel SE; Suurmeijer AJ; Hoekstra HJ
Cancer; 2006 Aug; 107(3):606-12. PubMed ID: 16804932
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
17. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.
Drilon AD; Popat S; Bhuchar G; D'Adamo DR; Keohan ML; Fisher C; Antonescu CR; Singer S; Brennan MF; Judson I; Maki RG
Cancer; 2008 Dec; 113(12):3364-71. PubMed ID: 18951519
[TBL] [Abstract][Full Text] [Related]
18. Clinical Efficacy of Carbon Ion Radiotherapy for Unresectable Chondrosarcomas.
Imai R; Kamada T; Araki N;
Anticancer Res; 2017 Dec; 37(12):6959-6964. PubMed ID: 29187480
[TBL] [Abstract][Full Text] [Related]
19. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
20. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
